Barua Reeta, Ferreyro Bruno, Detsky Michael, Thyagu Santhosh, Law Arjun, Munshi Laveena
Division of Medical Oncology, University of Toronto, Toronto, Canada.
Interdepartmental Division of Critical Care Medicine, Sinai Health System, University of Toronto, Mount Sinai Hospital, 600 University Avenue, 18-206, Toronto, ON, M5G 1X5, Canada.
Int J Hematol. 2022 Dec;116(6):929-936. doi: 10.1007/s12185-022-03429-2. Epub 2022 Aug 12.
Acute respiratory failure (ARF) is a frequent complication following hematopoietic cell transplantation (HCT). We aimed to characterize the etiologies of ARF in patients who died in the intensive care unit following HCT based on autopsy findings. We then evaluated agreement between the clinical and pathologic diagnosis.
We performed a chart review of all HCT patients who died and underwent autopsy in our ICU between 2006-2016. We evaluated the presumed clinical diagnosis and confidence in the diagnosis by chart review, the pathologic diagnosis on autopsy, and whether the clinical-pathologic diagnoses were concordant. When there was discordance, we evaluated whether knowledge of the pathology could have changed management.
Thirteen patients underwent autopsy after dying. Infection was the presumed cause in 11/13 cases. The clinical and pathologic diagnoses were concordant in 6/13(46%). In the seven discordant cases (all clinically diagnosed as infection), autopsy revealed two non-infectious inflammatory causes, one post-transplant lymphoproliferative disorder, and three non-bacterial infectious etiology. Pathologic findings may have changed management in 7/13(54%) cases.
In a subset of HCT-recipients who died from respiratory failure, discordance was frequent between clinical and pathologic diagnoses. The risks and benefits of obtaining tissue to improve our diagnostic accuracy requires further evaluation.
急性呼吸衰竭(ARF)是造血细胞移植(HCT)后常见的并发症。我们旨在根据尸检结果,对HCT后在重症监护病房死亡患者的ARF病因进行特征描述。然后我们评估了临床诊断与病理诊断之间的一致性。
我们对2006年至2016年间在我们重症监护病房死亡并接受尸检的所有HCT患者进行了病历审查。我们通过病历审查评估了推测的临床诊断和对诊断的信心、尸检的病理诊断以及临床病理诊断是否一致。当出现不一致时,我们评估病理知识是否会改变治疗方案。
13例患者死亡后接受了尸检。11/13例推测病因是感染。临床诊断与病理诊断在6/13例(46%)中一致。在7例不一致的病例中(均临床诊断为感染),尸检发现2例非感染性炎症病因、1例移植后淋巴细胞增殖性疾病和3例非细菌性感染病因。病理结果可能在7/13例(54%)中改变了治疗方案。
在一部分因呼吸衰竭死亡的HCT受者中,临床诊断与病理诊断之间经常存在不一致。获取组织以提高诊断准确性的风险和益处需要进一步评估。